Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma

Cytokine

Volumn 64, Issue 2, 2013, Pages 516-522

  Kim, Min Ju ^a   Jang, Jeong Won ^a   Oh, Byong Sun ^a   Kwon, Jung Hyun ^a   Chung, Kyu Won ^a   Jung, Hyun Suk ^a   Jekarl, Dong Wook ^a   Lee, Seungok ^a  

^a Bupyeong gu   (South Korea)

Author keywords

Acute phase proteins; Cytokines; Hepatocellular carcinoma; Inflammation; Interleukin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CYTOKINE; DOXORUBICIN; EPIRUBICIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; IODINATED POPPYSEED OIL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER SIZE; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CONTROLLED STUDY; CYTOMETRIC BEAD IMMUNOASSAY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOASSAY; INFLAMMATION; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ACUTE-PHASE PROTEINS; AFP; ALANINE AMINOTRASFERASE; ALT; ASPARTATE AMINOTRANSFERASES; AST; CYTOKINES; HCC; HEPATOCELLULAR CARCINOMA; IFN-Γ; IL; INFLAMMATION; INTERFERON-Γ; INTERLEUKIN; PORTAL VEIN THROMBOSIS; PVT; T HELPER CELL; TACE; TH; TNF-Α; TRANSARTERIAL CHEMO-EMBOLIZATION; TUMOR NECROSIS FACTOR-Α; Α-FETOPROTEIN;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HEPATIC ARTERY; HEPATITIS; HUMANS; INFLAMMATION MEDIATORS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TRANSAMINASES; TUMOR BURDEN;

EID: 84885190711     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.07.021     Document Type: Article

References (27)

1. Bruix J., Sala M., Llovet J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004, 127:179-188.
2. Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. Gastroenterol Hepatol 2012, 27:89-93.
3. Yoshida T., Kanai T., Monden M., Kita Y., Sakon M., Gotoh M., et al. Immunological and histological analyses of transarterial immuno-embolization therapy (TIE) in operable patients with hepatocellular carcinoma. Gan to Kagaku Ryoho 1994, 21:2111-2114.
4. Kitaoka S., Shiota G., Kawasaki H. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C. Hepatogastroenterology 2003, 50:1569-1574.
5. Momiyama K., Nagai H., Sumino Y. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy. Cancer Chemother Pharmacol 2009, 64:271-277.
6. Jang J.W., Oh B.S., Kwon J.H., You C.R., Chung K.W., Kay C.S., et al. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. Cytokine 2012, 60:686-693.
7. Budhu A., Wang X.W. The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 2006, 80:1197-1213.
8. Porta C., De Amici M., Quaglini S., Paglino C., Tagliani F., Boncimino A., et al. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann Oncol 2008, 19:353-358.
9. Chau G.Y., Wu C.W., Lui W.Y., Chang T.J., Kao H.L., Wu L.H., et al. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg 2000, 231:552-558.
10. Kuang D.M., Peng C., Zhao Q., Wu Y., Chen M.S., Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2010, 51:154-164.
11. Jiang R., Tan Z., Deng L., Chen Y., Xia Y., Gao Y., et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011, 54:900-909.
12. Hsia C.Y., Huo T.I., Chiang S.Y., Lu M.F., Sun C.L., Wu J.C., et al. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Eur J Surg Oncol 2007, 33:208-212.
13. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990, 11:443-449.
14. Prieto J. Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol 2008, 48:380-381.
15. Lee Y., Park U.S., Choi I., Yoon S.K., Park Y.M., Lee Y.I. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clin Cancer Res 1998, 4:1711-1717.
16. Kanaoka Y., Yagi T., Sadamori H., Matsukawa H., Matsuda H., Inagaki M., et al. Analysis of host response to hepatectomy by simultaneous measurement of cytokines in the portal vein, caval vein and radial artery. J Int Med Res 2002, 30:496-505.
17. Ueda T., Sakabe T., Oka M., Maeda Y., Nishida M., Murakami F., et al. Levels of interleukin (IL)-6, IL-8, and IL-1 receptor antagonist in the hepatic vein following liver surgery. Hepato-Gastroenterology 2000, 47:1048-1051.
18. Ren X., Hu B., Colletti L.M. IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastroint Liver Physiol 2010, 298:74-80.
19. Jin X., Zimmers T.A., Perez E.A., Pierce R.H., Zhang Z., Koniaris L.G. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 2006, 43:474-484.
20. Seifert J.K., Stewart G.J., Hewitt P.M., Bolton E.J., Junginger T., Morris D.L. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg 1999, 23:1019-1026.
21. Liang S.C., Nickerson-Nutter C., Pittman D.D., Carrier Y., Goodwin D.G., Shields K.M., et al. IL-22 induces an acute-phase response. J Immunol 2010, 185:5531-5538.
22. Radaeva S., Sun R., Pan H.N., Hong F., Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004, 39:1332-1342.
23. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Karow M., Flavell R.A. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007, 27:647-659.
24. Matsuguchi T., Okamura S., Kawasaki C., Niho Y. Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein. Cancer Res 1990, 50:7457-7459.
25. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
26. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003, 101:2620-2627.
27. Martin-Orozco N., Muranski P., Chung Y., Yang X.O., Yamazaki T., Lu S., et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009, 31:787-798.